Journal of Infection and Public Health
Volume 3, Issue 2 , Pages 47-53, 2010

Prevention or treatment: The benefits of Trichomonas vaginalis vaccine

  • Sarah L. Cudmore
  • ,
  • Gary E. Garber

      Affiliations

    • Corresponding Author InformationCorresponding author at: Division of Infectious Diseases, Ottawa Hospital, General Campus, 501 Smyth Rd., Ottawa, ON, Canada K1H 8L6. Tel.: +1 613 737 8173; fax: +1 613 737 8099.

Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Rd., Ottawa, ON, Canada K1H 8M5

Received 15 July 2009; received in revised form 20 January 2010; accepted 25 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1876-0341(10)00004-3

doi:10.1016/j.jiph.2010.01.003

Journal of Infection and Public Health
Volume 3, Issue 2 , Pages 47-53, 2010